PDS Biotechnology Corp. (PDSB)
1.055
+0.02
(+2.43%)
USD |
NASDAQ |
Jun 10, 16:00
1.03
-0.02
(-2.37%)
After-Hours: 20:00
PDS Biotechnology Market Cap : 58.89M for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 09, 2026 | 57.49M |
| June 08, 2026 | 55.82M |
| June 05, 2026 | 56.93M |
| June 04, 2026 | 68.10M |
| June 03, 2026 | 60.28M |
| June 02, 2026 | 64.75M |
| June 01, 2026 | 63.63M |
| May 29, 2026 | 60.28M |
| May 28, 2026 | 59.72M |
| May 27, 2026 | 61.96M |
| May 26, 2026 | 61.40M |
| May 22, 2026 | 66.98M |
| May 21, 2026 | 64.75M |
| May 20, 2026 | 57.49M |
| May 19, 2026 | 55.82M |
| May 18, 2026 | 65.86M |
| May 15, 2026 | 74.79M |
| May 14, 2026 | 79.82M |
| May 13, 2026 | 74.23M |
| May 12, 2026 | 61.40M |
| May 11, 2026 | 72.56M |
| May 08, 2026 | 69.77M |
| May 07, 2026 | 63.63M |
| May 06, 2026 | 59.16M |
| May 05, 2026 | 59.16M |
| Date | Value |
|---|---|
| May 04, 2026 | 55.82M |
| May 01, 2026 | 54.74M |
| April 30, 2026 | 54.31M |
| April 29, 2026 | 53.60M |
| April 28, 2026 | 60.28M |
| April 27, 2026 | 51.91M |
| April 24, 2026 | 50.26M |
| April 23, 2026 | 51.80M |
| April 22, 2026 | 72.00M |
| April 21, 2026 | 74.79M |
| April 20, 2026 | 72.00M |
| April 17, 2026 | 73.12M |
| April 16, 2026 | 71.44M |
| April 15, 2026 | 75.91M |
| April 14, 2026 | 59.16M |
| April 13, 2026 | 60.84M |
| April 10, 2026 | 60.28M |
| April 09, 2026 | 59.72M |
| April 08, 2026 | 55.26M |
| April 07, 2026 | 51.24M |
| April 06, 2026 | 43.56M |
| April 02, 2026 | 35.44M |
| April 01, 2026 | 33.84M |
| March 31, 2026 | 33.77M |
| March 30, 2026 | 29.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abeona Therapeutics, Inc. | 304.52M |
| ACADIA Pharmaceuticals, Inc. | 3.636B |
| Alnylam Pharmaceuticals, Inc. | 38.87B |
| Savara, Inc. | 1.041B |
| Vericel Corp. | 1.910B |
Market Cap Related Metrics
| Price to Book Value | 15.13 |
| Price | 1.055 |
| Earnings Yield | -63.56% |